tiprankstipranks
Trending News
More News >
Alumis Inc. (ALMS)
:ALMS
US Market
Advertisement

Alumis Inc. (ALMS) Stock Forecast & Price Target

Compare
178 Followers
See the Price Targets and Ratings of:

ALMS Analyst Ratings

Strong Buy
7Ratings
Strong Buy
7 Buy
0 Hold
0 Sell
Based on 7 analysts giving stock ratings to
Alumis
Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ALMS Stock 12 Month Forecast

Average Price Target

$19.33
▲(316.59% Upside)
Based on 7 Wall Street analysts offering 12 month price targets for Alumis Inc. in the last 3 months. The average price target is $19.33 with a high forecast of $25.00 and a low forecast of $14.00. The average price target represents a 316.59% change from the last price of $4.64.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","8":"$8","14":"$14","20":"$20","26":"$26"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$19.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$14.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,8,14,20,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.13,5.735384615384615,7.340769230769231,8.946153846153846,10.551538461538462,12.156923076923078,13.762307692307694,15.367692307692309,16.973076923076924,18.57846153846154,20.183846153846154,21.78923076923077,23.394615384615385,{"y":25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.13,5.299230769230769,6.468461538461538,7.637692307692307,8.806923076923077,9.976153846153846,11.145384615384614,12.314615384615383,13.483846153846152,14.65307692307692,15.822307692307689,16.99153846153846,18.16076923076923,{"y":19.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4.13,4.889230769230769,5.648461538461539,6.407692307692308,7.1669230769230765,7.926153846153847,8.685384615384615,9.444615384615386,10.203846153846154,10.963076923076922,11.722307692307693,12.481538461538463,13.240769230769232,{"y":14,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":12.69,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.7,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.67,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.31,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.27,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.86,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.48,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.65,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.24,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.83,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.29,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.02,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.13,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$25.00Average Price Target$19.33Lowest Price Target$14.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on ALMS
Leerink Partners
Leerink Partners
$29$20
Buy
331.03%
Upside
Assigned
08/15/25
Wall Street Analysts Are Bullish on Top Materials Picks
Wells Fargo Analyst forecast on ALMS
Wells Fargo
Wells Fargo
$17
Buy
266.38%
Upside
Reiterated
08/15/25
Analysts' Opinions Are Mixed on These Materials Stocks: Alumis Inc. (NASDAQ: ALMS) and Mosaic Co (NYSE: MOS)2Q25 Recap—Slight Delay on A-005 Ph2 Start; Setup for Shares Remains Good Heading into 2026; Reiterate Overweight
Morgan Stanley Analyst forecast on ALMS
Morgan Stanley
Morgan Stanley
$23$22
Buy
374.14%
Upside
Reiterated
08/15/25
Morgan Stanley Sticks to Their Buy Rating for Alumis Inc. (ALMS)Table data – Overweight; PT changed from 23.00 to 22.00.
Cantor Fitzgerald Analyst forecast on ALMS
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterated
08/14/25
Alumis Inc. (ALMS) Receives a Buy from Cantor Fitzgerald
Oppenheimer Analyst forecast on ALMS
Oppenheimer
Oppenheimer
$25
Buy
438.79%
Upside
Reiterated
08/14/25
H.C. Wainwright Analyst forecast on ALMS
H.C. Wainwright
H.C. Wainwright
$14
Buy
201.72%
Upside
Reiterated
08/14/25
Alumis Inc.: Strong Buy Rating Backed by Promising Drug Candidate and Strategic PositioningValuation and Risks. Using a discounted cash flow (DCF)-based approach, we derive a firm value of $1.7B and a 12- month price objective of $14 per share, which includes the estimated end-2Q26 cash position of ~$262M and ~115M shares outstanding. We assign a 60% probability of approval to envu in PsO and 20% probability of approval to envu in SLE. We do not ascribe value to sales of envu in psoriatic arthritis (PsA), although this indication should be viable given positive pivotal data for Sotyktu (deucravacitinib). We employ an 12% discount rate and 2% terminal growth rate.
Guggenheim Analyst forecast on ALMS
Guggenheim
Guggenheim
$18
Buy
287.93%
Upside
Initiated
06/10/25
Alumis resumed with a Buy at GuggenheimAlumis resumed with a Buy at Guggenheim
TR | OpenAI - 4o Analyst forecast on ALMS
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Reiterated
04/22/25
AI Generated ArticleAI Generated Article
Robert W. Baird Analyst forecast on ALMS
Robert W. Baird
Robert W. Baird
$25$17
Buy
266.38%
Upside
Reiterated
02/07/25
Alumis price target lowered to $17 from $25 at BairdAlumis price target lowered to $17 from $25 at Baird
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on ALMS
Leerink Partners
Leerink Partners
$29$20
Buy
331.03%
Upside
Assigned
08/15/25
Wall Street Analysts Are Bullish on Top Materials Picks
Wells Fargo Analyst forecast on ALMS
Wells Fargo
Wells Fargo
$17
Buy
266.38%
Upside
Reiterated
08/15/25
Analysts' Opinions Are Mixed on These Materials Stocks: Alumis Inc. (NASDAQ: ALMS) and Mosaic Co (NYSE: MOS)2Q25 Recap—Slight Delay on A-005 Ph2 Start; Setup for Shares Remains Good Heading into 2026; Reiterate Overweight
Morgan Stanley Analyst forecast on ALMS
Morgan Stanley
Morgan Stanley
$23$22
Buy
374.14%
Upside
Reiterated
08/15/25
Morgan Stanley Sticks to Their Buy Rating for Alumis Inc. (ALMS)Table data – Overweight; PT changed from 23.00 to 22.00.
Cantor Fitzgerald Analyst forecast on ALMS
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Reiterated
08/14/25
Alumis Inc. (ALMS) Receives a Buy from Cantor Fitzgerald
Oppenheimer Analyst forecast on ALMS
Oppenheimer
Oppenheimer
$25
Buy
438.79%
Upside
Reiterated
08/14/25
H.C. Wainwright Analyst forecast on ALMS
H.C. Wainwright
H.C. Wainwright
$14
Buy
201.72%
Upside
Reiterated
08/14/25
Alumis Inc.: Strong Buy Rating Backed by Promising Drug Candidate and Strategic PositioningValuation and Risks. Using a discounted cash flow (DCF)-based approach, we derive a firm value of $1.7B and a 12- month price objective of $14 per share, which includes the estimated end-2Q26 cash position of ~$262M and ~115M shares outstanding. We assign a 60% probability of approval to envu in PsO and 20% probability of approval to envu in SLE. We do not ascribe value to sales of envu in psoriatic arthritis (PsA), although this indication should be viable given positive pivotal data for Sotyktu (deucravacitinib). We employ an 12% discount rate and 2% terminal growth rate.
Guggenheim Analyst forecast on ALMS
Guggenheim
Guggenheim
$18
Buy
287.93%
Upside
Initiated
06/10/25
Alumis resumed with a Buy at GuggenheimAlumis resumed with a Buy at Guggenheim
TR | OpenAI - 4o Analyst forecast on ALMS
TR | OpenAI - 4o
TR | OpenAI - 4o
Hold
Reiterated
04/22/25
AI Generated ArticleAI Generated Article
Robert W. Baird Analyst forecast on ALMS
Robert W. Baird
Robert W. Baird
$25$17
Buy
266.38%
Upside
Reiterated
02/07/25
Alumis price target lowered to $17 from $25 at BairdAlumis price target lowered to $17 from $25 at Baird
Stocks with the Highest Top Analyst Consensus in the Basic Materials Sector
Find stocks in the Basic Materials sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alumis Inc.

1 Month
xxx
Success Rate
3/9 ratings generated profit
33%
Average Return
+3.84%
assigned a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of +3.84% per trade.
3 Months
xxx
Success Rate
3/9 ratings generated profit
33%
Average Return
-13.96%
assigned a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -13.96% per trade.
1 Year
Thomas SmithLeerink Partners
Success Rate
4/9 ratings generated profit
44%
Average Return
-22.21%
assigned a buy rating 18 days ago
Copying Thomas Smith's trades and holding each position for 1 Year would result in 44.44% of your transactions generating a profit, with an average return of -22.21% per trade.
2 Years
xxx
Success Rate
4/9 ratings generated profit
44%
Average Return
-21.08%
assigned a xxx
rating 18 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 44.44% of your transactions generating a profit, with an average return of -21.08% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ALMS Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
14
13
5
5
8
Buy
3
3
1
2
2
Hold
2
2
1
0
0
Sell
1
1
0
0
0
Strong Sell
0
0
0
0
0
total
20
19
7
7
10
In the current month, ALMS has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ALMS average Analyst price target in the past 3 months is 19.33.
Each month's total comprises the sum of three months' worth of ratings.

ALMS Financial Forecast

ALMS Earnings Forecast

Next quarter’s earnings estimate for ALMS is -$0.92 with a range of -$1.09 to -$0.80. The previous quarter’s EPS was $0.77. ALMS beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 44.42% of the time in the same period. In the last calendar year ALMS has Outperformed its overall industry.
Next quarter’s earnings estimate for ALMS is -$0.92 with a range of -$1.09 to -$0.80. The previous quarter’s EPS was $0.77. ALMS beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 44.42% of the time in the same period. In the last calendar year ALMS has Outperformed its overall industry.

ALMS Sales Forecast

Next quarter’s sales forecast for ALMS is $3.14M with a range of $0.00 to $5.00M. The previous quarter’s sales results were $2.67M. ALMS beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 46.69% of the time in the same period. In the last calendar year ALMS has Outperformed its overall industry.
Next quarter’s sales forecast for ALMS is $3.14M with a range of $0.00 to $5.00M. The previous quarter’s sales results were $2.67M. ALMS beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 46.69% of the time in the same period. In the last calendar year ALMS has Outperformed its overall industry.

ALMS Stock Forecast FAQ

What is ALMS’s average 12-month price target, according to analysts?
Based on analyst ratings, Alumis Inc.’s 12-month average price target is 19.33.
    What is ALMS’s upside potential, based on the analysts’ average price target?
    Alumis Inc. has 316.59% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ALMS a Buy, Sell or Hold?
          Alumis Inc. has a consensus rating of Strong Buy which is based on 7 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Alumis Inc.’s price target?
            The average price target for Alumis Inc. is 19.33. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $25.00 ,the lowest forecast is $14.00. The average price target represents 316.59% Increase from the current price of $4.64.
              What do analysts say about Alumis Inc.?
              Alumis Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
                How can I buy shares of ALMS?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis